RecruitingNCT04204499
Analysis of Screen-detected Lung Cancers' Genomic Traits
Sponsor
University College, London
Enrollment
526 participants
Start Date
Aug 10, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective, observational cohort study of patients undergoing surgical resection for low dose CT (LDCT) screen-detected lung cancer (detected through the SUMMIT study- ClinicalTrials.gov Identifier: NCT03934866/ lung screening programmes), in which translational research is a fundamental aspect.
Eligibility
Min Age: 50 YearsMax Age: 77 Years
Inclusion Criteria3
- Diagnosed with confirmed lung cancer or probable lung cancer via LDCT screening.
- Planned for, or completed primary surgical resection either for histologically confirmed lung cancer, or strongly suspected lung cancer.
- Able to provide written informed consent (or verbal informed consent for participants consenting to retrospective diagnostic samples and data collection only).
Exclusion Criteria2
- Treatment with neoadjuvant therapy for current lung malignancy as per local MDT treatment decision.
- Known Active Human Immunodeficiency Virus (HIV), Hepatitis B virus, Hepatitis C Virus or Syphilis.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04204499
Related Trials
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Empathic Communication Skills (ECS) Training
NCT0545684112 locations
Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block
NCT066185991 location
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667100 locations